Terumo Neuro Announces Two WISE Study Publications Reporting 0% New Bleeds or Rebleeds Through One Year Following WEB™ Treatment in Ruptured and Unruptured Aneurysm CohortsFindings from the largest prospective WEB pooled dataset strengthen the clinical evidence supporting WEB treatment across distinct ruptured and unruptured aneurysm cohorts.
Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial AneurysmsLargest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence
Terumo Neuro and Tulane University School of Medicine’s Dr. Kendrick Johnson Release Educational Video Highlighting the Importance of Stroke Awareness and Equitable Healthcare in Honor of World Stroke Day 2024
In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson, Assistant Professor of Neurosurgery at Tulane University School of Medicine, to release a compelling educational video focused on raising awareness about stroke education and the critical need for equitable healthcare access.
MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic Growth
MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.
